Silicon Laboratories SLAB Q1 2026 Earnings BetterThanExpected Bottom Line Drives Slight Stock Uptick STRL Q1 2026 Earnings EPS Surges Past Estimates on Strong Execution BURU Q3 2023 Earnings Significant Loss Per Share Amid PreRevenue Stage SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten MPLX Q1 2026 Earnings EPS Misses Street Estimates as Margins Face Pressure SLN Q4 2024 Earnings Positive EPS Amid Continued Clinical Progress